SGRY earnings: real EPS beat/miss history, analyst consensus Buy, P/E -25.69. Updated 2026-07-23.
Surgery Partners (SGRY) Research Hub
Surgery Partners (SGRY) trades on NASDAQ, US in the Healthcare (Medical - Care Facilities) sector. As of 2026-09-11, shares last closed at 14.38 USD (+1.84%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -25.69, market cap 2.05B. This hub links to the full technical, earnings and options research available for SGRY.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Care Facilities) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 14.38 USD (+1.84%) |
| 52-week range | 13.52 USD – 17.44 USD |
| Trend regime | Range |
| 14-day RSI | 40.7 (Bearish) |
| Trailing P/E | -25.69 |
| Market cap | 2.05B |
| Dividend yield | 0.00% |
Available research for SGRY
Covered Call on SGRY: how it works, illustrative setup around the real 14.38 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SGRY: how it works, illustrative setup around the real 14.38 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SGRY: how it works, illustrative setup around the real 14.38 USD price, max profit/loss, breakeven and when to use it. Educational.
SGRY technical analysis: range, last 14.38 USD, RSI 40.7, 52w range 13.52 USD–17.44 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is SGRY in?
Surgery Partners (SGRY) is classified under Healthcare (Medical - Care Facilities), listed on NASDAQ, US.
Is SGRY in an uptrend or downtrend?
As of 2026-09-11, SGRY is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SGRY's trailing P/E ratio?
SGRY's trailing P/E is -25.69, with a market cap of 2.05B. See the earnings research page for full valuation detail.